Stocks GXI
ETRGerresheimer AG (GXI)
We have not processed filings for Gerresheimer AG yet. This page fills in on its own once we have read them.
What Gerresheimer AG does
Gerresheimer manufactures glass and plastic packaging, as well as drug delivery devices for the healthcare industry. Its products include injection vials, ampoules, syringes, insulin pens, and inhalers. The company sells these products to pharmaceutical companies, biotechnology firms, and cosmetics manufacturers. Its shares trade on ETR under the ticker GXI.
Earnings: every quarter and the next report date
Latest SEC filings
Questions about GXI
What does Gerresheimer AG do?
Gerresheimer manufactures glass and plastic packaging, as well as drug delivery devices for the healthcare industry. Its products include injection vials, ampoules, syringes, insulin pens, and inhalers. The company sells these products to pharmaceutical companies, biotechnology firms, and cosmetics manufacturers. Its shares trade on ETR under the ticker GXI.
Theses that mention GXI
- The real bottleneck in the GLP-1 boom is not the molecules, it is glass, stoppers and injector pens Live
Follow GXI
Get an email when Gerresheimer AG files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Gerresheimer AG tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.